AJU IB Investment

Latest statistics and disclosures from AJU IB Investment's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ACLX, RLYB, KYMR, SEER, XLO, and represent 97.26% of AJU IB Investment's stock portfolio.
  • Reduced shares in these 3 stocks: ACLX (-$54M), KYMR (-$34M), Sutro Biopharma.
  • AJU IB Investment was a net seller of stock by $-90M.
  • AJU IB Investment has $23M in assets under management (AUM), dropping by -80.21%.
  • Central Index Key (CIK): 0001710065

Tip: Access up to 7 years of quarterly data

Positions held by AJU IB Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for AJU IB Investment

AJU IB Investment holds 7 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Arcellx Common Stock (ACLX) 63.9 $15M -78% 224k 65.20
 View chart
Rallybio Corp (RLYB) 18.2 $4.1M 755k 5.49
 View chart
Kymera Therapeutics (KYMR) 6.7 $1.5M -95% 20k 77.81
 View chart
Seer Com Cl A (SEER) 6.6 $1.5M 816k 1.83
 View chart
Xilio Therapeutics (XLO) 1.9 $428k 668k 0.64
 View chart
Rapt Therapeutics Com New 1.8 $421k 12k 33.87
 View chart
Sutro Biopharma 0.9 $203k -90% 18k 11.57
 View chart

Past Filings by AJU IB Investment

SEC 13F filings are viewable for AJU IB Investment going back to 2021